Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
11.34
-0.02 (-0.22%)
At close: May 28, 2025, 4:00 PM
11.29
-0.05 (-0.40%)
After-hours: May 28, 2025, 4:04 PM EDT
Amarin Corporation Employees
Amarin Corporation had 275 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
275
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$778,589
Profits / Employee
-$319,735
Market Cap
234.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
AMRN News
- 21 days ago - Amarin Corporation plc (AMRN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 4 weeks ago - Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 - GlobeNewsWire
- 6 weeks ago - Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday - Benzinga
- 7 weeks ago - Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change - GlobeNewsWire
- 7 weeks ago - Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors - GlobeNewsWire
- 2 months ago - Concerned Shareholder Group Urges Amarin's Board of Directors to Initiate a Strategic Review Following Two Years of Underperformance - Business Wire
- 2 months ago - New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo - GlobeNewsWire